Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tiziana Life Sciences Ltd
(NQ:
TLSA
)
0.9000
+0.0500 (+5.88%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Tiziana Life Sciences Ltd
< Previous
1
2
3
4
5
Next >
Tiziana Life Sciences adds to treasury with $3.4 million in non-dilutive funding
June 28, 2024
Tiziana Life Sciences adds to treasury with $3.4 million in non-dilutive funding
Via
News Direct
12 Health Care Stocks Moving In Monday's After-Market Session
June 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
June 07, 2024
Via
Benzinga
EXCLUSIVE: Top Tesla Options Trades Recommended By Trading Expert
May 15, 2024
Trading expert Anne-Marie Baiynd shared option trade ideas for Tesla on Benzinga's YouTube, discussing potential positive catalysts and bullish strategies.
Via
Benzinga
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
April 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
April 19, 2024
Via
Benzinga
7 Battered Blue-Chip Stocks to Bounce From Your Portfolio This Spring
April 19, 2024
Not all big companies are doing well in the stock market. For various reasons, these battered blue-chip stocks are struggling mightily.
Via
InvestorPlace
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 18, 2024
Via
Benzinga
3 EV Stocks to Buy on the Dip: March 2024
March 29, 2024
The electric vehicle market slump has significantly impacted many EV stocks to buy - But the slump will not last forever.
Via
InvestorPlace
Topics
Electric Vehicles
Exposures
Electric Vehicles
3 EV Stocks to Buy for the Next Bull Run: March 2024
March 28, 2024
EV stocks have broadly underperformed the market in 2024, which has, in turn, created a number of opportunities to buy at a bargain.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 05, 2024
Via
Benzinga
7 Over-Hyped Stocks to Sell Before They Plunge
January 25, 2024
It wasn't too long ago that these stocks were considered hot commodities. But now they're just overhyped stocks to sell.
Via
InvestorPlace
Tesla Shares Hardly Damaged Despite Recall: Full Self-Driving Is Elon Musk's 'Holy Grail,' Analyst Says
December 13, 2023
Tesla shares fell only slightly. And auto recalls are nothing new. Recall how, in 1981, Ford issued a recall on 21 million vehicles.
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Don't Get Caught In Equity Rally Hype: Lessons From 2023 To Remember In 2024
December 12, 2023
After a volatile 2023, equity markets appear to be rallying into 2024. Can they keep it up?
Via
Benzinga
Tiziana Expects To Start Enrolling Patients in Its Phase 2 Clinical Trial To Treat Secondary Progressive Multiple Sclerosis (SPMS) Using its Novel Intranasal Monoclonal Antibody Foralumab
December 01, 2023
--News Direct--
Via
News Direct
Tiziana Expects To Start Enrolling Patients In Its Phase 2 Clinical Trial To Treat Secondary Progressive Multiple Sclerosis (SPMS) Using Its Novel Intranasal Monoclonal Antibody Foralumab
November 30, 2023
This month, Tiziana Life Sciences (NASDAQ: TLSA) expects to start enrolling patients for a phase 2a trial of Foralumab, an immunomodulation therapy for Secondary Progressive Multiple Sclerosis (SPMS)...
Via
Benzinga
SPDR ETF Report For Tuesday, November 21
November 22, 2023
Via
Talk Markets
Topics
ETFs
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
October 19, 2023
We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders need to know about this morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 18, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
October 18, 2023
Pre-market stock movers are a hot topic worth checking out on Wednesday and we have all the latest news happening this morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 17, 2023
Via
Benzinga
Tiziana Life Sciences reveals "exciting" clinical data from latest MS trial
October 17, 2023
--News Direct--
Via
News Direct
Tiziana Life Sciences reports six-month PET scan results for MS patients
October 16, 2023
--News Direct--
Via
News Direct
Tiziana to Announce Six-Month Human Safety and Biomarker Data at the ECTRIMS Annual Congress, Following-Up from Positive Outcomes Data Presented in June
October 13, 2023
--News Direct--
Via
News Direct
Exposures
Product Safety
Tiziana To Announce Six-Month Human Safety And Biomarker Data At The ECTRIMS Annual Congress, Following-Up From Positive Outcomes Data Presented In June
October 12, 2023
Tiziana (NASDAQ: TLSA) is following up with anticipated human data and announced the acceptance of a late-breaking poster at the 39th Congress of the Europea
Via
Benzinga
Tiziana Advances Phase 2 Site Selection for Its Lead Clinical Program in Non-Active Secondary Progressive Multiple Sclerosis (SPMS) and The Company Prepares for Six-Month Clinical Data Update
October 05, 2023
--News Direct--
Via
News Direct
Cathie Wood Sells $25 Million In Tesla Stock As TSLA Flashes Aggressive Buy Signal
October 05, 2023
Wood's Ark Invest unloaded nearly 100,000 TSLA shares Wednesday.
Via
Investor's Business Daily
Tiziana Advances Phase 2 Site Selection For Its Lead Clinical Program In Non-Active Secondary Progressive Multiple Sclerosis (SPMS) And The Company Prepares For Six-Month Clinical Data Update
October 04, 2023
Tiziana Life Sciences Ltd. (NASDAQ: TLSA) recently announced the Company has initiated site selection for its lead intranasal anti-CD3 monoclonal antibody drug c
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.